Summary
The growth hormone (GH) response to apomorphine HCl (Apo) (0.75 mg sc), a dopamine (DA) receptor agonist, was assessed in healthy chronic alcoholics without cirrhosis (N=20) and in patients with alcoholic cirrhosis both with (N=5) and without (N=14) hepatic encephalopathy (HE). A significant number of cirrhotic patients with (P<0.004) and without (P<0.002) HE had an impaired GH response (peak increment<5 ng/ml) compared with non-cirrhotic individuals. An impaired GH response was independent of the presence of HE. The magnitude of the GH response was unrelated to plasma oestrone, oestradiol, or progesterone concentrations but was significantly correlated with plasma testosterone levels (P<0.01). None of the patients with an abnormally low testosterone concentration showed a normal GH response. None of the subjects with HE showed an arousal response to Apo. These results suggest that DA receptor sensitivity is decreased in liver cirrhosis and that this decrease is related to inadequate circulating levels of testosterone. The occurrence of HE is independent of impaired DA function. The present study only evaluates DA function in the hypothalamic-pituitary axis and therefore may not reflect changes in other regions of brain.
Similar content being viewed by others
References
Abraham, G. E., Odell, W. D., Swerdloff, R. S., Hopper, K.: Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle. J. Clin. Endocr. Metab.34, 312–318 (1972).
Abramsky, O., Goldschmidt, Z.: Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa. Surgery75, 188–193 (1974).
Baker, H. W. G., Burger, H. G., de Kretser, D. M., Dulmanis, A., Hudson, B., O'Connor, S., Paulsen, C. A., Purcell, N., Rennie, G. C., Seah, C. S., Taft, H. P., Wang, C.: A study of the endocrine manifestations of hepatic cirrhosis. Quart. J. Med.45, 145–178 (1976).
Baldy-Moulinier, M., Bories, P., Michel, H., Passouant, P.: Encéphalopathies hépatiques; étude hémodynamique et métabolique de l'influence de l'ammoniaque et de la L-dopa. Rev. Neurol.133, 175–189 (1977).
Chajek, T., Berry, E. M., Friedman, G., Abramsky, O.: Treatment of acute hepatic encephalopathy with L-dopa. Postgrad. Med. J.53, 262–265 (1977).
Colon, A. R., Sandberg, D. H.: Hepatic encephalopathy treated with L-dopa, recovery followed for 18 months. Pediatrics51, 1105–1106 (1973).
Conn, H. O., Daughaday, W. H.: Cirrhosis and diabetes. V. Serum growth hormone levels in Laennec's cirrhosis. J. Lab. Clin. Med.76, 678–688 (1970).
Cuilleret, G., Pomier-Layrargues, G., Pons, F., Cadilhac, J., Michel, H.: Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy. Gut21, 565–569 (1980).
Elithorn, A., Lunzer, M., Weinman, J.: Cognitive deficits associated with chronic hepatic encephalopathy and their response to levodopa. J. Neurol. Neurosurg. Psychiat.38, 794–798 (1975).
Ettigi, P., Lal, S., Martin, J. B., Friesen, H. G.: Effect of sex, oral contraceptives and glucose loading on apomorphine-induced growth hormone secretion. J. Clin. Endocr. Metab.40, 1094–1098 (1975).
Ettigi, P., Nair, N. P. V., Lal, S., Cervantes, P., Guyda, H.: Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy. J. Neurol. Neurosurg. Psychiat.39, 870–876 (1976).
Fischer, J. E., Baldessarini, R. J.: False neurotransmitters and hepatic failure. Lancet2, 75–79 (1971).
Fischer, J. E., Baldessarini, R. J.: Pathogenesis and therapy of hepatic coma. Progr. Liv. Dis.5, 363–397 (1976).
Fischer, J. E., Funovics, J. M., Falcao, H. A., Wesdorp, R. I. C.: L-Dopa in hepatic coma. Ann. Surg.183, 386–391 (1976).
Friesen, H. G., Guyda, H., Hardy, J.: Biosynthesis of human growth hormone and prolactin. J. Clin. Endocr. Metab.31, 611–624 (1970).
Girard, P. E., Trillet, M., Kopp, N.: Correction par L-dopa des manifestations neurologiques d'une encéphalopathie porto-cave chronique. Rev. Neurol.127, 560–563 (1972).
Hernandez, A., Zorrilla, E., Gershberg, H.: Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease. J. Lab. Clin. Med.73, 25–33 (1969).
Illig, R., Prader, A.: Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. J. Clin. Endocr. Metab.30, 615–618 (1970).
Jellinger, K., Riederer, P.: Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study on human postmortem material. J. Neural Transm.41, 275–286 (1977).
Jellinger, K., Riederer, P., Kleinberger, G., Wuketich, St., Kothbauer, B.: Brain monoamines in human hepatic encephalopathy. Acta Neuropathol. (Berl.)43, 63–68 (1978).
Jorge, A. D., Sanchez, D.: Die Wirkung des L-Dopa im Coma hepaticum. Schweiz. Rundschau Med.62, 868–872 (1973).
Kley, H. K., Keck, E., Kruskemper, H. L.: Estrone and estradiol in patients with cirrhosis of the liver: effects of ACTH and dexamethasone. J. Clin. Endocr. Metab.43, 557–560 (1976).
Knell, A. J., Davidson, A. R., Williams, R., Kantamaneni, B. D., Curzon, G.: Dopamine and serotonin metabolism in hepatic encephalopathy. Brit. Med. J.1, 549–551 (1974).
Lal, S., de la Vega, C. E., Sourkes, T. L., Friesen, H. G.: Effect of apomorphine on human growth hormone secretion. Lancet2, 661 (1972).
Lal, S., de la Vega, C. E., Sourkes, T. L., Friesen, H. G.: Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum. J. Clin. Endocr. Metab.37, 719–724 (1973).
Lal, S., Aronoff, A., Garelis, E., Sourkes, T. L., Young, S. N., de la Vega, C. E.: Cerebrospinal fluid homovanillic acid, 5-hydroxyindoacetic acid, lactic acid, and pH before and after probenecid in hepatic coma. Clin. Neurol. Neurosurg.77, 142–154 (1974).
Lal, S., Martin, J. B., de la Vega, C. E., Friesen, H. G.: Comparison of the effect of apomorphine and L-dopa on serum growth hormone levels in normal men. Clin. Endocr.4, 277–285 (1975).
Lal, S., Guyda, H., Bikadoroff, S.: Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men. J. Clin. Endocr. Metab.44, 766–770 (1977).
Lal, S., Nair, N. P. V., Guyda, H.: Effect of lithium on hypothalamic-pituitary dopaminergic function. Acta Psychiat. Scand.57, 91–96 (1978).
Lal, S., Nair, N. P. V., Cervantes, P., Pulman, J., Guyda, H.: Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion. Acta Psychiat. Scand.59, 173–179 (1979).
Lal, S., Nair, N. P. V., Cervantes, P., Guyda, H.: Use of drug-induced growth hormone and prolactin responses in psychiatric research. In: Progress in Psychoneuroendocrinology (Brambilla, F., Racagni, G., de Wied, D., eds.), pp.295–307. Elsevier-North Holland Biomedical Press. 1980.
Lal, S., Etienne, P., Thavundayil, J., Nair, N. P. V., Collier, B., Rastogi, R., Guyda, H., Schwartz, G.: Effect of choline on central dopaminergic function in normal subjects. J. Neural Transm.50, 29–37 (1981 a).
Lal, S., Thavundayil, J., Nair, N. P. V., Etienne, P., Rastogi, R., Schwartz, G., Pulman, J., Guyda, H.: Effect of sleep deprivation on dopamine receptor function in normal subjects. J. Neural Transm.50, 39–45 (1981 b).
Louidice, T. A., Tulman, A., Buhac, I.: L-Dopa and hepatic encephalopathy. New Y. St. J. Med.79, 364–366 (1979).
Lunzer, M., James, I. M., Weinman, J., Sherlock, S.: Treatment of chronic hepatic encephalopathy with levodopa. Gut15, 555–561 (1974).
Maany, I., Frazer, A., Mendels, J.: Apomorphine: effect on growth hormone. J. Clin. Endocr. Metab.40, 162–163 (1975).
Martin, L. G., Clark, J. W., Connor, T. B.: Growth hormone secretion enhanced by androgens. J. Clin. Endocr. Metab.28, 425–428 (1968).
Merimee, T. J., Fineberg, S. E.: Studies of the sex based variation of human growth hormone secretion. J. Clin. Endocr. Metab.33, 896–902 (1971).
Michel, H., Cauvet, G., Granier, P. M., Bali, J. P., Andre, R., Cuilleret, G.: Treatment of cirrhotic hepatic encephalopathy by l-dopa. A double-blind study of 58 patients. Digestion15, 232–233 (1977).
Michel, H., Solere, M., Granier, G., Cauvet, G., Bali, J. P., Pons, F., Bellet-Hermann, H.: Treatment of chronic hepatic encephalopathy with L-dopa. A control trial. Gastroenterology79, 207–211 (1980).
Missala, K., Lal, S., Sourkes, T. L.: O-Methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviour. Europ. J. Pharmacol.22, 54–58 (1973).
Morgan, M. Y., Jakobovits, A. W., Elithorn, A., James, I. M., Sherlock, S.: Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy. New Engl. J. Med.296, 793–794 (1977).
Morgan, M. Y., Jakobovits, A. W., James, I. M., Sherlock, S.: Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology78, 663–670 (1980).
Nair, N. P. V., Lal, S., Cervantes, P., Yassa, R., Guyda, H.: Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia. Neuropsychobiol.5, 136–142 (1979).
Nilsson, K. O.: Lack of effect of hyperglycaemia on apomorphine-induced growth hormone release in normal man. Acta Endocrinol. (Kbh.)80, 230–236 (1975).
Panerai, A. E., Salerno, F., Manneschi, M., Cocchi, D., Müller, E. E.: Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease. J. Clin. Endocr. Metab.45, 134–140 (1977).
Parkes, J. D., Sharpstone, P., Williams, R.: Levodopa in hepatic coma. Lancet2, 1341–1343 (1970).
Peniche, J. H., Posada, J. C. G., Arroyave, S. T.: Coma hepatico. Tratamiento con L-dopa. Comunicacion preliminar. Prensa Med. Mexicana37, 161–162 (1972).
Pimstone, B. L., Le Roith, D., Epstein, S., Kronheim, S.: Disappearance rates of plasma growth hormone after intravenous somatostatin in renal and liver disease. J. Clin. Endocr. Metab.41, 392–395 (1975).
Podolsky, S., Zimmerman, H. J., Burrows, B. A., Cardarelli, J. A., Pattavina, C. G.: Potassium depletion in hepatic cirrhosis. A reversible cause of impaired growth hormone and insulin response to stimulation. New Engl. J. Med.288, 644–648 (1973).
Samaan, N. A., Stone, D. B., Eckhardt, R. D.: Serum glucose, insulin and growth hormone in chronic hepatic cirrhosis. Arch. Int. Med.124, 149–152 (1969).
Sarrazin, A., Emerit, J., Olivier, L., Rebelo, F., Bousquet, O.: Traitement du coma hépatique par l-dopa. Premiers résultats. Presse Méd.79, 2226–2227 (1971).
Sourkes, T. L., Lal, S.: Apomorphine and its relation to dopamine in the nervous system. Adv. Neurochem.1, 247–299 (1975).
Stefanini, M., Hetherington, E. N.: Levodopa in hepatic failure. J. Amer. Med. Assoc.220, 1247 (1972).
Tolis, G, Lal, S., Pinter, E.: Reduced growth hormone responses to apomorphine and L-dopa in obesity (Symposium of the International Society of Psychoendocrinology, Viségard), pp. 335–339. Publishing House of the Hungarian Academy of Sciences. 1975.
Tsang, D., Lal, S.: Effect of monoamine receptor agonists and antagonists on cyclic AMP accumulation in human cerebral cortex slices. Canad. J. Physiol. Pharmacol.55, 1263–1269 (1977).
Tsang, D., Lal, S., Sourkes, T. L., Ford, R. M., Aronoff, A.: Studies on cyclic AMP in different compartments of cerebrospinal fluid. J. Neurol. Neurosurg. Psychiat.39, 1186–1190 (1976).
Uribe, M., Farca, A., Marquez, M. A., Garcia-Ramos, G., Guevara, L., Briones, A., Gil, S.: Treatment of chronic portal systemic encephalopathy with bromocriptine. A double-blind controlled trial. Gastroenterology76, 1347–1351 (1979).
Weiss, A., Pitman, E. R., Javdan, P.: Arousal response in hepatic encephalopathy with L-dopa. Am. J. Gastroenterol.62, 497–503 (1974).
Yamaguchi, K., Fukushima, H., Uzawa, H.: Response of human growth hormone, prolactin, and thyrotropin to thyrotropin releasing hormone in liver cirrhosis and diabetes mellitus. Endocrinol. Jap.26, 81–88 (1979).
Young, S. N., Lal, S., Sourkes, T. L., Feldmuller, F., Aronoff, A., Martin, J. B.: Relationship between tryptophan in serum and CSF and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of the liver and probenecid administration. J. Neurol. Neurosurg. Psychiat.38, 322–330 (1975).
Young, S. N., Lal, S.: CNS tryptamine metabolism in hepatic coma. J. Neural Transm.47, 153–161 (1980).
Zanoboni, A., Zanoboni-Muciaccia, W.: Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis. J. Clin. Endocr. Metab.45, 576–578 (1977).
Zieve, L.: Hepatic encephalopathy: summary of present knowledge with an elaboration on recent developments. Progr. Liv. Dis.6, 327–341 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lal, S., Oravec, M., Aronoff, A. et al. Hypothalamic-pituitary dopaminergic function in hepatic failure in man. J. Neural Transmission 53, 7–21 (1982). https://doi.org/10.1007/BF01243516
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01243516